Related Experiment Video
Updated: Aug 14, 2026
11:58
Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Astrocytes in Parkinson's disease: Beyond support, toward therapy
Shuang Wu1, Wenjun Wang1, Linli Yang1
1School of Clinical Medical Sciences, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China.
Experimental Neurology
|August 12, 2026
Summary
Astrocytes, crucial glial cells, play a key role in Parkinson's disease (PD) pathogenesis and treatment. Targeting astrocytes offers new therapeutic strategies for this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Cell Biology
- Neurodegenerative Diseases
Background:
- Parkinson's disease (PD) is characterized by dopaminergic neuron loss.
- Traditionally, PD research focused on neuronal dysfunction.
- Astrocytes, the most abundant glial cells, are increasingly recognized for their role in PD.
Purpose of the Study:
- To explore the multifaceted roles of astrocytes in Parkinson's disease.
- To highlight astrocytes as potential therapeutic targets for PD.
- To advocate for a glia-inclusive approach in PD research.
Main Methods:
- Review of current literature on astrocyte function in PD.
- Analysis of therapeutic strategies targeting astrocytes.
- Discussion of innovative delivery systems for astrocyte-targeted interventions.
Main Results:
- Astrocytes can act as both protectors and contributors to PD progression.
- Targeting astrocytes offers therapeutic potential via reprogramming, polarization, and modulation of cellular processes.
- Novel strategies like gene therapy and exosomes show promise for overcoming the blood-brain barrier.
Conclusions:
- A paradigm shift towards a glia-inclusive framework is needed in PD research.
- Astrocytes are central to developing disease-modifying therapies for Parkinson's disease.
- Targeting astrocytes presents a promising avenue for multifactorial PD interventions.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:04Glial Cells
Overview